• Like
  • Comment
  • Favorite

Crescita Therapeutics Q4 EPS $(0.04) Down From $(0.01) YoY, Sales $5.955M Down From $6.902M YoY

Benzinga03-31 19:44

Crescita Therapeutics (TSX:CTX) reported quarterly losses of $(0.04) per share. This is a 300 percent decrease over losses of $(0.01) per share from the same period last year. The company reported $5.955 million in sales this quarter. This is a 13.72 percent decrease over sales of $6.902 million the same period last year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet
 
 
 
 

Most Discussed

 
 
 
 
 

7x24